臺灣博碩士論文加值系統

中 文 總 摘 要
樟芝 (子實體) 是台灣稀少特有的菇類，相傳具有解毒、抗癌及抗氧化等功效。本研究的目是有二：第一、探討樟芝菌絲體的醱酵液(FCBA)或樟芝菌絲體的萃取液(AEMA)是否具保護血管內皮細胞受自由基傷害及提升抗氧化能力。研究顯示，單獨低濃度 (＜100μl/ml) 的FCBA或AEMA會促進內皮細胞生長；然而，高濃度 (＞200μl/ml) 的FCBA或AEMA內皮細胞會造成毒性。內皮細胞加入FCBA 或 AEMA會抑制自由基誘發劑－AAPH (15 mM)對內皮細胞的氧化傷害；包括，存活率(Cell viability)明顯上昇，PGI2 生成減少，細胞內SOD活性增加。此外，加入FCBA 或 AEMA亦會保護AAPH誘發內皮細胞凋亡 (Apoptosis)；包括，TUNEL實驗細胞凋亡的現象明顯減少，且會抑制Cytochrome C 、caspase-3、bax蛋白的表現及PARP的裂解減少，而增加bcl-2、catalase 、SOD 蛋白的表現。第二、研究樟芝保護低密度脂蛋白(Low density lipoprotein，LDL)氧化作用。研究發現，LDL加入FCBA 或 AEMA會抑制自由基誘發劑－銅離子 (CuSO4) 或AAPH 對LDL的氧化傷害；包括，延長共軛雙烯 (Conjugate diene) 的延遲作用時間(Lag phase)，降低脂質過氧化物丙二醛(MDA)形成，延緩脂質過氧化物(Lipid peroxide)產生，抑制脂蛋白B(Apo B)的裂解，保護膽固醇不被氧化，及抑制LDL的電位改變 (Electrophoretic mobility)。總結，樟芝(FCBA或AEMA)可以保護血管內皮細胞自由基誘發的氧化傷害及抑制氧化型LDL的形成，進而降低動脈硬化的發生。

英 文 總 摘 要
Antrodia camphorata (here we mean its fruit body), a rare mushroom in Taiwan , traditionally is used as an antidote, anticancer and antioxidant drug. The first purpose of this study was to evaluate the ability of Fermented culture broth of A. camphorata (FCBA) 、aqueous extract of mycelia of A. camphoraat (AEMA) to protect human umbilical vein endothelia cell(HUVEC) from free radical-induced oxidative damge in vitro and investigate its antioxidant role. Results show that exposure of HUVEC to low concentration (<100 μl/ml) of FCBA or AEMA increases endothelial cells growth; however as exposure to high concentration (>200 μl/ml) of those drugs causes cellular toxicity. Oxidative stress and apoptosis were induced by (AAPH). HUVEC preincubated with FCBA or AEMA prior to the AAPH exposure resulted in a dose-dependent increase in resistnace to oxidative stress; results had showed that an increase in cell viability and intracelluar SOD activity, while a decrease in PGI2 production as the cells incubated with AAPH were pretreated with increasing concentrations of FCBA and AEMA; Also, preincubated with FCBA or AEMA protects HUVECs from AAPH-induced apoptosis; results had showed a decrease of apoptotic cells detected by TUNEL assay, an inhibition of cytochrome c release, bax production, caspase-3 and PARP degradation, while a increase in bcl-2, catalase and SOD expression. The second purpose of this study was to evaluate the ability of FCBA and AEMA to protect low density lipoprotein (LDL) from free radical (CuSO4)-induced oxidative damge in vitro. Pretreated with FCBA or AEMA protects LDL from CuSO4-induced oxidative damge in a dose- and time-dependent manner; results had showed an enlongation lag phase of conjuage diene, delayed lipid peroxide production, a decreas of apo B synhtesis, protection of cholesterol from oxidation, and inhibit the electrophoretic mobility of LDL as LDL incubated with AAPH were pretreated with increasing concentrations of FCBA and AEMA. In conclusion, both FCBA and AMEA protect endothelial cells from free-radical induced-oxidative stress and apoptosis and reduce ox-LDL production, further reducing the risk of atherosclerosis.

目 錄
中文總摘要………………………………………………………………………..1 英文總摘要………………………………………………………………………2
第一章……………………………………………………………………………3
壹、 摘 要…………………………………………………………………4
貳、 前 言 6
參、 文獻整理……………………………………………………………..6
肆、 實驗品器材…………………………………………………………23
伍、 實驗方法…………………………………………………………….26
陸、 實驗結果…………………………………………………………….41
柒、 討 論 53
第二章………………………………………………………………………….55
壹、 摘 要…………………………………………………………………56
貳、 前 言、文獻整理…………………………………………………..58
參、 實驗品器材…………………………………………………………68
肆、 實驗方法……………………………………………………………70
伍、 實驗結果……………………………………………………………80
陸、 討 論 85
總 結………………………………………………………………………….87
圖 表…………………………………………………………………………88
參考文獻…………………………………………………………………

Allain C. C., Poon L. S.,Chen C. S. G., Richmond W., and Fu. P. C. (1974) Enzyme Determination of Total Serum Cholesterol . Clin. Chem.20 (4)：470-475.
Aniranm, M. (1993) Modified froms of low density lipoprotein and atherosclerosis. Atherosclerosis. 98: 981-9.
Baynes John, Dominiczak M. H. (1999). Medical Biochemistry. P211、P520.
Beetens, J.R., Halliwell, B., Gutteridge, J.M.C., (1984) Oxygen toxicity, oxygen radicals,transition metals and disease. Biochem. J. 219(1): 1-14.
Biveris, A. ( 1977) mitochondrial production of superoxide radical and hydrogen peroxidase. Adv. Exp. Med. Biol. 78: 67-82.
Boveris, A. ＆Chance, B. ( 1973) The mitochondrial generation of soperoxide radical and peroxide: General propertics and effect of hyperbaric oxygen. Biochem. J. 134: 707-716.
Bunting, S., Gryglewski, R., Moncada, S. ＆Vane, J.R. (1976) Arterial walls generate from prostanglandin endoperoxide a substance (prostaglandin X) wich relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins. 12: 897-913.
Carew, T.E., Schwenke, D.C.＆ Steinber, D. (1987) Antiatherigentic effect of probucol unrelated to its hypercholesterolemiceffect: evidence that: antioxidants in vico xan selectively inhibit low density lipoprotein degradation on macrophages rich fatty streaks slowing the progression of atherosclerosis in th WHHL rabbit. Proc. Natal. Acad. Sci. 84: 7725-9.
Chang, T. T. and Chiang, H. C. (1995). Three new triteroenoids from Antrodia cinnamomea. J. Natural Products 58(3):365-371.
Chen, C. H.,Yang, S. W. , and Shen, Y. C. (1995). New steroid acids from Antrodia cinnamomea, a fugal parasite of Cinnamomum micranthum. J. Nat. PRO. 58: 1655-1661.
Cherng, I. H., Wu, D. P., Cherng, I. H. Ueng, C. H. (1996) . A sesquiterpene lactone, phenyl and biphenyl compounds from Antrodia cinnamonea. Phytochemistrt, 39(3): 613-616
Chiu, H.C., Jeang, J.R. ＆Shieh, S.M. (1994) Increased oxidizability of plasma low density lipoprotein from patient with coronary arterydisease. Biochim.Biophys. 1225: 200-208.
Coene, M.C., Verheyen, A., Zonnekeynm, L. ＆Herman, A.G. (1986) Biphasic response of intimal prostacyclin production during the development of experimental atherosis. Prostaglandins. 32: 319-334.
Cosulich, S.C., Savory, P.J. ＆Clarke, P.R. (1999) Bcl-2 regulates amplification of caspase action by cytochrome. Brief. Communication . 9: 147-150.
D’Angelo, V., Villa, S., Musliwiec, M., Donati, M.B., Gaetano, G., (1978) Defective fibrinolytic and prostacyclin like activity in human atheromatous plaques. Thromb Haemost. 39: 535-536.
Dembinska, K.A., Grglewska, T., Zmuda, A. ＆Gryglewski, R.J. (1977) The generation of prosatcyclin by arteries and by coronary vascular bed is reduced in experimental atherosclerosis in rabbit. Prostaglandins. 14: 1025-1034.
DiCorleto, P.E. ＆Chisolm, G.M. (1986) Participation of endothelium in the development of the atherosclerotic plaque. Prog. Lipid Res. 25: 365-374.
Doweney, J. (1990) Free radicals and thire involvwment during the long-term myocardial ischemia and reperfusion. Annu. Rev. Physionl. 52: 487-504.
Esterbaure, H., Gebicki, J., Puhl, H. ＆Jurgens, G. (1992) The role of lipid peroxidation and antioxidats in oxidative modification of LDL. Free Radic. Boil. Med. 13: 341-390.
FitzGerald, G.A., Friedman, L.A., Miyamori, I.O., Grady, J.O. and Lewis, P. J. A double placrbo controlled crosovern dtudy of Prostacyclin in man. Life Sci. 25: 665-672.
Forman, H.J., Boveis, A. (1982) Superoxide radical and hydrogen peroxide in mitochondria. Free radic. biol. New York: 65-90.
Frangos, J.A., Skin, S.G., McIntire, L.V. ＆Ives, C.L. (1985) Flow effect on prostacyalin production by cultured human endothlial cells. Scinece. 227: 1477-1479.
Frankel EN. (1984) Chemistry of free radical and singlet oxidation of lipids. Progress in Lipid Research. 23(4):197-221.
FitzGerald GA. Friedman LA. Miyamori I. O''Grady J. Lewis PJ. (1979) A double blind placebo controlled crossover study of prostacyclin in man. Life Sciences. 25(8):665-72.
Frankel. E. N. (1991). Recent advances in lipid oxidation oxidation. J. Sci. Food Argiacl. 54:495-511..
Frei, B. (1994) Reactive oxygen species and antioxidant vitamines: mechanism of action. Am. J. Med. 97 (supp 3A): 5S-13S.
Furchgott, R.F.and Zadawzki, J.V. (1980) The obligatony role of e ndothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288: 373-376.
Gordon, M. H. (1990) The mechanism of antioxidation in vitro. Ch. L, in Food Antioxidants, B. J. F. Hudson (Ed.) p.1-18 Elservier Applied Scinece, London and New York.
Gorman, R.R., Bunting, S. ＆Miller, O.V. (1977) Modulation of human plateleet adenylate cyclase by prostacyclin (PGX). Prostaglandins. 13: 377-388.
Halliwell B. (1984) Oxygen is poisonous: the nature and medical importance of oxygen radicals. Medical Laboratory Sciences. 41(2):157-71.
Hene A.Kleinveld, Heidi L. M. Hak-Lemmers, Anton F. H. Stalenhoef, and Pierre N. M. Demacker, (1992) Improved Measurment of Low-Density-Lipoprotein Susceptibility to Copper-Induced Oxidation:Application of A short Procedrue for isolating Low-Density Lipoprotein. Clin. Chem. 38(10): 2066-2072
Halliwell Barry, Gutteridge John M. C. (1999) Free Rradicals in Biology and Medicine. Third edition p69, 294, 295, 633.
Hseu Y. C., Chan W. C., Hseu Y. T., Lee C. Y., Yech Y. J., Chen P. C., Chen J. Y., Yan. H. L., (2002).Protection of oxidative damage by aqueous extract from Antrodia camphorata mycelia in normal human erthrocytes.Life Science 71: 469-482.
Lab, J. (1994) Lipid oxidation and inflammation-induced intimal fibrosis in Coronary heart disease. Clin. Med. 124: 162-8.
Jaffe, E.A., Nachmam, R.L., Becker, C.D. ＆Minick, C.R. (1973) Culture of human endothelial cells derived from umbilical veins. J. Clinic. Inves. 52: 2745-56.
Jaffe, E.A., Nachman, R.L., Becker, C.G. ＆Minic, C.R. (1973) Culture of human endothelial cells derived from umbilical veins.Indentification by morphologic and immunologic criteria. J. Clin. Inves. 52: 2745-56.
Jimi S. Saku K. Uesugi N. Sakata N. Takebayashi S.(1995) Oxidized low density lipoprotein stimulates collagen production in cultured arterial smooth muscle cells. Atherosclerosis. 116(1):15-26.
John, R., Vane, D.F. ＆Regina, M.B. (1995 ) Bpharm Pharmacodynamic Profile of Prostacyclin. Am. J. Cardiol. 75: 3A-10A.
Kariya, K.; Nakamura, K.; Nomoto, K.; Matama, S.; Saigenji, K. (1992) Mimicking of superoxide disumtase activity by protein-bound polysaccharide of Coriolus versicolor QUEL, and oxidative stress relief for cancer patients. Mol. Biother. 4 : 40-46.
Karmazyn, M. ＆Moffant, M.P. (1985) Toxic properties of arachidonic acid on normal, ischemic and reperfused hearts. Indrirect evidence for free radical involvement . Prostaglandins Leukotrienes Med. 17: 251-264.
Kawagishi H. Ishiyama D. Mori H. Sakamoto H. Ishiguro Y. Furukawa S. Li J. (1997) Dictyophorines A and B, two stimulators of NGF-synthesis from the mushroom Dictyophora indusiata. Phytochemistry. 45(6): 1203-5.
Kellogg, E. (1975) Superoxidase, hydrogen peroxide and singlet oxygen in lipid peroxidation by xanthine oxidase system. J. Biol. Chem. 250: 8812-8817.
Kleinved, H., Demacker, P.N. ＆Stalenhoef AF. (1994) Comparative study on the LDL to oxidation and the progression of atherosis in Wantanabe Heritable Hyperlipidemic rabbits. Arterioscl. Thromb. 14: 1386-91.
Kloner, R., Przyklenk, K. ＆Whittaker, P. (1989) Deleterious effects of oxygen radicals in ischemia reperfusion. Circulation. 80(5): 1115-1127.
Kluck, R.M., Bossy-Wetzel E., Green, D.R. ＆Newmeyer, D.D. (1997) The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science. 275: 1132-1136.
Lee. I. H., Huang. R. L., Chen. C. T., Chen . H. C., Hsu. W. C., Lu. M. K. (2002) Antrodia camphorata polysaccharides exhibit anti-hepatitis B virus effects. FEMS Microbiology Letter 209 : p63-67
Liu, F.; Ooi, V. E. C.; Chang, S. T. (1997) Free radical scavenging activity of mushroom polysaccharide extracts. Life Sci. 60: 763-771.
Luch, S.M. ＆Frei, B. (1993) Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein, J. lipoprotein Res. 34(10): 1745-53.
McCord, J; Foridovich, I. (1968) The reduction of cytochrome c by milk xanthine oxidase. J. Biol. Chem. 243: 5753-5760.
Miauno, T.;Hagiwara, T.; Nakamura, T.;Itl, H.; Shimura, K.; Sumiya, T. ; Askura, A. (1990) Antitumor activity and some properties of water-soluble polysaccharides from “Himematsutake,” the fruitinf body of Agaricus blazei murill.Agric .Biol. Chem. 54: 2889-2896.
Mizuno, T. (1995) Bioactive biomolecules of mushrooms:Food fruction and medicinal effect of mushroom fungi. Food Reviws Interational. 11(1): 7-21.
Moncada, S. ＆Vane, J.R. (1979) Arachidonic acid metabolites and the interacteractions between platelets and blood vessel walls. N. Engl. J. Med. 300: 1142.
Morigiwa A. Kitabatake K. Fujimoto Y. Ikekawa N. (19860) Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chemical & Pharmaceutical Bulletin. 34(7):3025-8.
Parthasarathy, S. ＆Rankin, S.M. (1992) Role of oxidised low density lipoprotein in atherogenesis. Prog Lipid Res. 31: 127-143.
Pervaiz, S., Harriman, A. ＆Gulliya, K.S. (1992) Protein damage by photoproducts of merocyanine 540. Free Radic. Bio. MED. 12: 389-96.
Prescott, S.M., Zimmerman, G.A. ＆Mclntyre, T.M. (1984) Proc. Natl. Acad. Sci. USA. 81: 3534-3538.
Rattan,A.K. & Arad, Y. (1998) Temporal and kinetic determinants of the inhbition of LDL oxidation by N-acetylcystein (NAC). Atherosclerosis. 138: 319-327.
Rau, L. (1991) Hypertension,endothelium, anf cardiovascular risk factor, Am. J. Med. 90 (24): 13s.
Reaven, P. (1996) The role of dietary fat in LDL oxidation and atherosclerosis. Nutr. Metab. Cardiovasc Dis. 6: 57-64.
Ross, R. (1986) The pathogenesis of atherosclerosis- an update. N. Engl. J. Med. 314: 488-500.
Sambrook, J., Fritttsch, E.F., Maniantis, T. (1989) Molecular Cloning: A Laboratory Manuuuual, 2nd ed.Cold Spring Harbor,NY, Clod Spring Harbor Laboratory.
Sato, I., Kaji, K. ＆Murota, S. (1995 ) Age related decline in cytokine induced nitric oxide synthase activation and apoptosis in cultured endothelial cells: minimal involvement of nitric oxide in the apoptosis. Mechanisms of Ageing & Development. 81(1): 27-36.
Schwartz CJ. Kelley JL. Nerem RM. Sprague EA. Rozek MM. Valente AJ. Edwards EH. Prasad AR. Kerbacher JJ. Logan SA.(1989) Pathophysiology of the atherogenic process. American Journal of Cardiology. 64(13):23G-30G.
Simpson, P.J., Mitsos, S.E., Ventura, A., Gallagher, K.P., Fantone, J.C., Abrams, G.D., Schork, M.A. ＆Lucchesi, B.R. (1987) Prostacyclin proeects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. Am. J. Heart. 113:129-137.
Song T. Y., Yen G. C., 2002. Antioxidant Porperties of Antrodia camphorata in Submerged Culture. J. Agric. Food Chem. 50: 3322-3327.
Stampfer, M.J., Hennekens, C.H., Mason, J.E., Colditz, G.A., Rosner, B. ＆Willet, W.C. (1993) Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328: 1444-1449.
Steinberg, D. (1991) Antiocidats and atherosclerosis; a current assessment. Ciriulation. 84: 1420-1425.
Steinberg, L. and Witiztum, J. (1990) lipoprotein and atherogenesis:Current concepts. JAMA. 264: 3047-305
Tateson, J.E., Moncada, S. ＆Vane, J.R. (1977) Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plates. Prostaglandins. 13: 389-397.
Tsai, Z.T. ＆Liaw, S.L. (1982) The use and effect of Ganodorna, Taichung, Taiwan: Shen-Yun Inc, pp 116-7.
Volpi, N. ＆Tarugi, P. (1999) The protective effect on Cu2+- and AAPH-mediated oxidation of human low-density lipoproteins depends on glcosominoglycan structure. Biochimie. 81(10): 955-963.
Voss, R .,Ten Hoor . F., and Matthias, F. (1983). Prosatcyclin production and atherosclerosis of rabbit aorta. Adv. Prostacyclin Throme Leukotriene Res. 11,469-474.
Wasser, S. P.; Weis, A. L. (1999) Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective. Crit. Rev. Immunol.19：65-96.
Willians, R.J., Motteram, J.M., Sharp. C.H. ＆Gallagher, P.J. (1992) Dietary vitamine E and the attenuation od early lesion formation on modificatied Wantanabe rabbits. Atherosclerosis. 94: 153-159.
Witztum, J.L. (1994) The oxidation hypothesis of atherosis. Lancet. 344: 793-5.
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. ＆Masaki, T. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332(6163): 411-415.
Yang, F.-C., and Liau, C.-B. (1998). The influence of environmental
conditions on polysaccharide formation by Ganoderma lucim in submerged cultures. Proc. Biochem. 33(50): 547-553.
Yang J. Liu X. Bhalla K. Kim CN. Ibrado AM. Cai J. Peng TI. Jones DP. Wang X. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. [see comments.]. Science. 275(5303):1129-32.
Zulueta, J.J., Yu, F.S., Herting, I.A., Thannickal, V.J. ＆Hassoun, P.M. (1995) Release of hydrogen peroxidase in response to hyoxia-reoxygenation: Role of an NAD(P)H oxidasee-like enzyme in endithelial cell plasma membrane. Am. J. RESP. Cell Mol. Biol. 12: 41-49.
水野卓、川合正允 (賴慶亮譯) ，1997，菇類的化學。國之編譯館，台北，台灣，409。
王伯徹，黃仁彰，食品工業，2002，5月，3-17。
卯曉嵐, 1989. 中國的食用和藥用大型真菌.微生物學通報16: 290-297。
行政院衛生署 : 衛生統計-台灣地區死因統計結果摘要(1996)。
吳俊逸，1996，松杉靈芝抗氧化性之研究，國立中與大學食品科學研究所碩士論文。
沈立言，2000，牛樟芝菌絲體醱酵萃取液對肝細胞生理機能性之影響，
8 9年保健食品研究開發計劃心得發表會 191-198。
林教彬，1996，靈芝現代研究/特性、裁培、成份、藥理、應用. 北京醫科大學/中國協和醫科大學聯合出版社，北京.212頁。.
林榮耀，靈芝及菇類等真菌類免疫調節蛋白之研究及探討其臨床應用性，生命科學簡訊，民國85年2月第1第十卷第二期。
林秀卿，1999，食用菇類之呈味品質和抗氧化性質之評估，國立中與大學食品科學研究所碩士論文。
王伯徹、邱世浩、黃仁彰，1998，食用菇保健食品專輯，5月份，1-35。
徐錦堂，1997，第一章 緒論，中國藥用真菌學。徐錦堂主編。北京醫科大學、中國協和大學聯合出版社。
高曉薇，1991，台灣靈芝類屬新菌種樟芝三帖成份研究，台北醫學院。台北醫學院天然物醫學研究所.碩士論文。
許勝傑，陳清農，陳勁初，2000，樟芝宿主專一性之探討.台灣農業化學與食品科學：38(6)：533-539。
陳勁初、林文鑫、陳清濃、許勝傑、黃仕政、陳炎鍊，2001，Fung. Sci. 16(1,2): 7-22.
陳勁初、陳建州、張基煌、毛正倫、喬長誠，2001，CCRC363963 姬松茸與樟芝菌絲體之毐性與至突變性之研究.中華民國保健食品學會二屆第一次會員大會。
黃坤正、丁懷謙、余俊強、何漣漪，2000，基因毐理與種物病理組織之系統分析，依「食品與製造系統及關鍵技術研發四年計劃（第四年度）」 計劃標號:007051-04:3-12。
黃鈴娟，2000，樟芝與姬松茸之抗氧化性質及多糖組成分析，國立中與大學食品科學研究所碩士論文。
廖英明，1998，.菇類中的許不了~樟芝.農業世界雜誌:第176期, 76-79.
潘素美、葉志新，1997，台灣食用藥用菇超氧歧化酉每含量之比較，中國農化會誌 35(2)：209-219.
戴宇昀，2001，樟芝菌絲體及子實體對四氯化碳及酒精誘導之慢性及急性肝損傷之保肝功能，國立中與大學食品科學研究所碩士論文。
簡秋源，姜宏哲、陳淑貞，1997.牛樟菇培養性狀及其三帖類成分分析之研究，牛樟生物學及育林技術研會論文集，台灣省林業試驗所，台北，台灣，133-137。
顏全良，1997，乳酸茵抗氧化之探討及對脂質氧化之抑制，國立中與大學食品科學研究所碩士論文。